Related Experiment Video

Updated: Apr 18, 2026

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on: July 12, 2018

9.4K

Correction: galectin-3 as a marker and potential therapeutic target in breast cancer

    Plos One
    |January 27, 2015
    PubMed

    Abstract:

    [This corrects the article DOI: 10.1371/journal.pone.0103482.].

    More Related Videos

    Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
    09:40

    Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

    Published on: October 4, 2019

    6.1K
    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
    07:41

    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

    Published on: May 17, 2019

    9.7K

    Related Experiment Videos

    Last Updated: Apr 18, 2026

    A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
    11:13

    A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

    Published on: July 12, 2018

    9.4K
    Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
    09:40

    Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

    Published on: October 4, 2019

    6.1K
    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
    07:41

    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

    Published on: May 17, 2019

    9.7K

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    9.2K
    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    9.2K

    Articles linked to this work by shared authors, journal, and citation graph.

    Artificial intelligence for women's reproductive health: A scoping review of global diagnostic trends, methodological gaps, and a translational research agenda for low-resource settings.

    PloS one·2026

    Emergy evaluation of ecological sustainability in Cananguchales (Mauritia flexuosa): A biocountable approach in the Amazonian foothills.

    PloS one·2026

    A CFD-based investigation of hydraulic regimes in overflow weir fishways.

    PloS one·2026

    A neuroevolution-driven agent-based model of coral larvae settlement.

    PloS one·2026

    Uncertainty-Aware structured decoding for Chinese Braille document transcription.

    PloS one·2026

    Atrial natriuretic peptide may inhibit motion sickness through reducing aldosterone-induced increase in endolymph volume of the inner ear.

    PloS one·2026

    A Markov model cost threshold analysis of potential hepatitis B virus cure regimens.

    Clinical and translational gastroenterology·2026

    Efficacy and safety of radiofrequency hyperthermia combined with immune checkpoint inhibitors and chemotherapy as first-line treatment for HER2-negative advanced gastric/gastroesophageal junction adenocarcinoma: A propensity score-matched study.

    Human vaccines & immunotherapeutics·2026

    Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Metastatic Well-Differentiated Neuroendocrine Tumors.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Clinical outcomes and blood-based biomarkers across two SABR-treated metastatic settings: oligoprogression under immune checkpoint inhibition and oligometastatic disease.

    Oncoimmunology·2026

    Is there a role for palliative care in CAR T-cell therapy?

    Current opinion in supportive and palliative care·2026

    Synergistic Antitumor Effects and Reduced Systemic Toxicity of Berberine Chloride Combined With Cisplatin in a Female BALB/c Mouse Xenograft Model.

    Cell biology international·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us